Cargando…

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID

PURPOSE: Metabolic detoxification with enzyme replacement therapy (ERT) promotes immune recovery in patients with adenosine deaminase (ADA)–deficient severe combined immunodeficiency (ADA-SCID). Elapegademase is a PEGylated recombinant bovine ADA ERT developed to replace the now-discontinued bovine-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorsey, Morna J., Rubinstein, Arye, Lehman, Heather, Fausnight, Tracy, Wiley, Joseph M., Haddad, Elie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276086/ https://www.ncbi.nlm.nih.gov/pubmed/36840835 http://dx.doi.org/10.1007/s10875-022-01426-y

Ejemplares similares

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
por: Secord, Elizabeth, et al.
Publicado: (2022)

Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion
por: Verma, S.K., et al.
Publicado: (2008)

Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
por: Gao, Zhao-wei, et al.
Publicado: (2022)

Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
por: Li, Gen, et al.
Publicado: (2015)

Diagnostic Value of Serum Adenosine Deaminase (ADA) Level for Pulmonary Tuberculosis
por: Salmanzadeh, Shokrollah, et al.
Publicado: (2015)

National experience with adenosine deaminase deficiency related SCID in Polish children
por: Dąbrowska-Leonik, Nel, et al.
Publicado: (2023)

Polymorphisme de l'adénosine déaminase (ada) dans l'espèce bovine
por: Ansay, M, et al.
Publicado: (1972)

Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations
por: Albalawi, Reem, et al.
Publicado: (2021)

Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)—Two Diseases That Exacerbate Each Other: Case Report
por: Bogdał, Anna, et al.
Publicado: (2021)

Atypical presentation of adenosine deaminase 2 deficiency with bi‐allelic ADA2 mutation
por: Al‐shaikh, Reem, et al.
Publicado: (2022)

Relation of serum adenosine deaminase (ADA) levels with sputum smear conversion in patients with pulmonary tuberculosis
por: Okutan, Oguzhan, et al.
Publicado: (2006)

Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study
por: Ntwari, Jules, et al.
Publicado: (2020)

Novel ADA2 Compound Heterozygous Mutations Resulting in Deficiency of Adenosine Deaminase 2 in a Pair of Siblings
por: Guo, Li, et al.
Publicado: (2021)

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2
por: Hong, Ying, et al.
Publicado: (2022)

ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer
por: Luo, Wenwen, et al.
Publicado: (2022)

Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
por: Hall, J. G., et al.
Publicado: (1979)

Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients
por: Farhan, Hanan Mohamed, et al.
Publicado: (2017)

Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life
por: Odumade, Oludare A., et al.
Publicado: (2021)

Soluble Ecto-5′-nucleotidase (5′-NT), Alkaline Phosphatase, and Adenosine Deaminase (ADA1) Activities in Neonatal Blood Favor Elevated Extracellular Adenosine
por: Pettengill, Matthew, et al.
Publicado: (2013)

Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient
por: Lanfranchi, Arnalda, et al.
Publicado: (2018)

Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
por: White, Shanna L., et al.
Publicado: (2022)

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
por: Lee, Jae-Geun, et al.
Publicado: (2011)

The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association
por: Nunes, Daniela Prudente Teixeira, et al.
Publicado: (2011)

Utility of adenosine deaminase (ADA), PCR & thoracoscopy in differentiating tuberculous & non-tuberculous pleural effusion complicating chronic kidney disease
por: Kumar, Sravan, et al.
Publicado: (2015)

Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-α (TNFα) concentration in chronic heart failure
por: Khodadadi, IrajI, et al.
Publicado: (2014)

Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones
por: Uchiyama, Toru, et al.
Publicado: (2021)

Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
por: Fratini, Elena Sophia, et al.
Publicado: (2023)

Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series
por: Canarutto, Daniele, et al.
Publicado: (2023)

Diagnostic Accuracy of Cerebrospinal Fluid (CSF) Adenosine Deaminase (ADA) for Tuberculous Meningitis (TBM) in Adults: A Systematic Review and Meta-Analysis
por: Prasad, Manoj Kumar, et al.
Publicado: (2023)

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
por: Zhulai, Galina, et al.
Publicado: (2022)

Adenosine deaminase activity in leukaemia.
por: Smyth, J. F., et al.
Publicado: (1975)

OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
por: Levy-Lahad, E, et al.
Publicado: (2013)

Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study
por: Perlepe, Garifallia, et al.
Publicado: (2021)

Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
por: Booth, Claire, et al.
Publicado: (2009)

Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
por: Zhou, Q, et al.
Publicado: (2013)

Neutropenia in patients with adenosine deaminase deficiency
por: Kim, Vy HD, et al.
Publicado: (2014)

Adenosine deaminase in exudative pleural effusions
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Adenosine deaminase deficiency: a review
por: Flinn, Aisling M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tj6g2kh4aaghdjoq7punibpidm